View More Recent Stories

May 28, 2015 10:09AM Threat Stack Names Brian M. Ahern as New Chairman & CEO
May 28, 2015 08:15AM Padlock Therapeutics Accelerates Pipeline Development Through Agreement with GSK
May 28, 2015 08:00AM Raze Therapeutics Announces Addition of Robert Copeland, PhD, to Scientific Advisory Board
May 21, 2015 08:00AM Jose-Carlos Gutiérrez-Ramos, Ph.D. Joins Synlogic as Chief Executive Officer
May 19, 2015 08:15AM Quartet Medicine Announces Scientific Advisory Board Comprising Academic and Industry Neuroscience Leaders
May 14, 2015 11:03AM Skillz Brings Live Streaming and Instant Replays to Mobile eSports
May 14, 2015 08:30AM Critical Outcome Technologies Strengthens Its Board
May 7, 2015 09:00AM Surface Oncology Appoints Detlev Biniszkiewicz as Chief Executive Officer
Apr 28, 2015 08:15AM Padlock Therapeutics Assembles Scientific Advisory Board with World Leaders in PAD Enzyme Biology and Autoimmune Disease
Apr 22, 2015 07:30AM Intellia Therapeutics Announces the Appointment of Dr. Sapna Srivastava as Chief Finance & Strategy Officer
Apr 22, 2015 07:30AM Intellia Therapeutics Announces Dr. Jennifer Doudna and Dr. Derrick Rossi to Join Company
Apr 21, 2015 03:10PM Founders Share Exchange Committed to Founders of Pre-Seed Stage Startups
Apr 20, 2015 07:00AM InsureMyTrip and Hopper Research show spike in travel to Europe this summer
Apr 9, 2015 12:34PM clypd Raises $19.4 Million in Series B Round Funding to Fuel Development of Programmatic TV Technology
Apr 8, 2015 08:15AM Padlock Therapeutics Initiates Collaborations with Three Leading Research Partners on the Biology of PAD Enzymes
Mar 31, 2015 08:15AM X-Chem and Navitor Pharmaceuticals Enter into License Agreement on Novel Small Molecules Targeting mTORC1 Activation
Mar 26, 2015 02:05PM Form 4 ZAFGEN, INC. For: Mar 24 Filed by: Atlas Venture Associates VII, Inc.
Mar 13, 2015 02:00PM Inmoji Partners With textPlus to Provide Peer-to-Peer Engagement in Mobile Messaging
Feb 12, 2015 02:15PM Form SC 13G Egalet Corp Filed by: Atlas Venture Fund VII L P
Feb 12, 2015 02:14PM Form SC 13G/A Horizon Pharma plc Filed by: ATLAS VENTURE FUND VI LP
Feb 12, 2015 02:13PM Form SC 13G ZAFGEN, INC. Filed by: Atlas Venture Fund VII L P
Feb 12, 2015 02:12PM Form SC 13G Vitae Pharmaceuticals, Filed by: ATLAS VENTURE FUND VI LP
Feb 4, 2015 07:20AM Medicines Co. (MDCO) Completes Annovation Biopharma Acquisition
Nov 28, 2011 06:31AM GSV Capital (GSVC) Increases Facebook Stake; Announces $21M in Investments
Dec 19, 2008 09:20AM Helicos BioSciences (HLCS) Announces $18.6 Million Private Placement
Dyne Therapeutics Appoints David Lubner to Board of Directors
Form 13F-HR Atlas Venture Life Scien For: Jun 30
View More Recent Stories